Search

Your search keyword '"Michael E. Weinblatt"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Michael E. Weinblatt" Remove constraint Author: "Michael E. Weinblatt" Journal arthritis & rheumatism Remove constraint Journal: arthritis & rheumatism
50 results on '"Michael E. Weinblatt"'

Search Results

2. Inhibition of Leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate

3. A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis

4. Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial

5. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: The accuracy of self-reported medication information in patient registries

6. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

7. Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis

8. Development and assessment of indicators of rheumatoid arthritis severity: Results of a Delphi panel

9. Infections and anti-tumor necrosis factor ? therapy

10. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders

11. Reply

12. Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

13. Etanercept in the treatment of adult patients with Still's disease

15. The end of rheumatoid factor as we know it?

16. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

17. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature review

18. Granulomatous lung disease occurring during etanercept treatment

19. Campath-1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

20. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

21. Synovial tissue response to treatment with campath-1h

22. Methotrexate in rheumatoid arthritis. a five-year prospective multicenter study

23. Lack of a renal–protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin a. results of a randomized, placebo–controlled trial

24. Methotrexate for Rheumatoid Arthritis

25. The effects of drug therapy on radiographic progression of rheumatoid arthritis. results of a 36-week randomized trial comparing methotrexate and auranofin

26. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis

27. PTPRCrheumatoid arthritis risk allele is also associated with response to anti-TNF therapy

28. Long-Term Prospective Study of Methotrexate in the Treatment of Rheumatoid Arthritis

29. Serious liver disease in a patient receiving methotrexate and leflunomide

30. The effects of cyclosporin a on eicosanoid excretion in patients with rheumatoid arthritis

31. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis

32. Reply

33. Reply

34. Reply

35. Evaluation of two interventions to reduce the ancillary costs of outpatient care for rheumatoid arthritis

37. Reply

38. Reply

39. Reduced joint counts in rheumatoid arthritis clinical trials

40. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

41. Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis.

42. Letters

44. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: Continued observations.

45. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.

46. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis

47. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

48. Chronic liver disease and still's disease

49. Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy

50. Reply

Catalog

Books, media, physical & digital resources